Company Description

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States.

It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery.

The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid.

Profusa, Inc. is based in Berkeley, California.

Profusa, Inc.

Country	United States
Founded	2009
Industry	Medical Devices
Sector	Healthcare
Employees	15
CEO	Jack Stover

Contact Details

Address: 626 Bancroft Way, Suite A Berkeley, California 94710 United States
Phone	925 997 6925
Website	profusa.com

Stock Details

Ticker Symbol	PFSA
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001859807
CUSIP Number	74319X405
ISIN Number	US74319X4051
Employer ID	86-3437271
SIC Code	3841

Key Executives

Name	Position
Jack E. Stover CPA	Chief Executive Officer and Executive Chairman
Dr. Chung-Bin Hwang Ph.D.	President
Fred S. Knechtel	Chief Financial Officer
William McMillan	Co-founder, Chief Scientific Officer and Head of Research
David Icke	Head of Digital Health Business
Sean Givens	Head of Government Business

Latest SEC Filings

Date	Type	Title
Aug 19, 2026	SCHEDULE 13D	Filing
Aug 19, 2026	10-Q	Quarterly Report
Aug 18, 2026	PRE 14A	Other preliminary proxy statements
Aug 14, 2026	NT 10-Q	Notification of inability to timely file Form 10-Q or 10-QSB
Aug 14, 2026	8-K	Current Report
Aug 4, 2026	SCHEDULE 13G/A	Filing
Jul 31, 2026	8-K	Current Report
Jul 27, 2026	8-K	Current Report
Jul 7, 2026	424B3	Prospectus
Jul 7, 2026	424B3	Prospectus

View All SEC Filings